-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$17.0077.27% Upside
ORIC Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover ORIC Pharmaceuticals, Inc.?
ORIC Pharmaceuticals, Inc. has been rated by research analysts at Stifel Nicolaus, H.C. Wainwright, Wedbush, Oppenheimer, Citigroup in the past 90 days.